Reports Q4 revenue $485.9M, consensus $481.69M. Noel Geoffroy, CEO, stated: “We reported fourth quarter net sales and adjusted diluted EPS that met the Outlook range we provided in January. During the quarter we saw strength in Wellness, OXO, Osprey, and International, and a better-than-expected contribution from Olive & June. Stepping back to look at the full fiscal year, we accomplished a number of important objectives, including taking the necessary and focused actions to Reset & Revitalize our brands and business, delivering the largest year of Project Pegasus savings, and adding an immediately accretive brand to our global portfolio with the acquisition of Olive & June. Our efforts to improve the health of our brands and our operating performance are producing results. In Fiscal 2025 we grew or maintained market share in five of our key categories in our U.S. measured channels, where seven of our brands hold number one or number two positions in their respective categories, and we grew international net sales.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HELE:
- Helen of Troy price target lowered to $70 from $91 at Canaccord
- HELE Earnings this Week: How Will it Perform?
- Helen of Troy price target lowered to $70 from $92 at Canaccord
- Helen of Troy price target lowered to $38 from $68 at UBS
- Helen of Troy shares appear oversold on tariff fears, says Canaccord